The Patent Finder

Kalobios Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Kalobios Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Kalobios Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,168,183Antibodies to granulocyte-macrophage colony-stimulating factor
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,017,674Antibodies to Granulocyte-Macrophage Colony-Stimulating Factor
Formerly held
In force
 · Low confidence
In forceLow confidence
US 8,642,035Anti-Trkb Antibodies
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,290,571Antibodies to EphA3
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,834,870Treatment of leukemias and chronic myeloproliferative diseases with antibodies to EphA3
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,045,539Anti-EMR1 antibodies
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,109,032Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrow
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,664,365Antibodies to EphA3
Formerly held
Lapsed on the fee record
Ended Mar 4, 2026 · USPTO record
Lapsed on the fee recordEnded Mar 4, 2026USPTO record
US 8,637,016EphA3 Antibodies for the Treatment of Solid Tumors
Formerly held
Lapsed on the fee record
Ended Jan 28, 2026 · High confidence
Lapsed on the fee recordEnded Jan 28, 2026High confidence
US 7,981,843Antibody specificity transfer using minimal essential binding determinants
Formerly held
Lapsed on the fee record
Ended Jul 19, 2023 · USPTO record
Lapsed on the fee recordEnded Jul 19, 2023USPTO record
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited